Facts from IQVIA · 2020. 6. 18. · 3 Indicator RUB USD EUR PACKS Value M03/YTD’20, Bln. 381 5,7 5,2 1,4 Growth M03/YTD’20% 31% 29% 33% 5,1% Market grew by 31% in value and by

© 2020. All rights reserved. IQVIA® is a registered trademark of IQVIA Inc. in the United States, the European Union, and various other countries.

Facts from IQVIA

M03 2020

1

Source: IQVIA databases: Retail (TRD Prices)

Cough&Cold Market: EphMRA3: J05B,L03A,L03B,R01A,R02A,R05A,R05C,R05D

C&C sales

Mln USD, M03/YTD’20

Growth

In percent in USD

C&C increases by 22% in USD and decreased by 12% in volume

EAEU & CIS, Russia Cough&Cold category in January-March 2020, Value in Mln. USD and Units

RUSSIA

TOTAL C&C MARKET

KAZAKHSTAN

BELARUS

UZBEKISTAN

AZERBAIJAN

4

MOLDOVA

KYRGYZSTAN

GEORGIA

MONGOLIA

813

663

42

32

30

12

10

8

8

4

ARMENIA

3

229

308

24

13

19

5

4

8

2

1

45%

71%

22%

32%

21%

21%

2%

32%

70%

50%

4%

8%

19%

3%

12%

2%

44%

16%

25%

59%

20%

13%

C&C sales

Mln Units, M03/YTD’20Growth

In percent in Units

Growth

In percent in Local Currency

28%

64%

22%

50%

16%

32%

35%

75%

78%

3%

2

Source: IQVIA database (TRD prices)

Source: IQVIA databases. Retail and Non-Retail (excluding food supplements and diagnostic agents), TRD Prices . Azerbaijan, Georgia and Armenia – retail only. Mongolia – Import

Total pharma sales

Bln USD, M03/YTD’20

Growth

In percent in USD

Total Market increases by 26% in USD and by 8% in volume

EAEU & CIS, Russia Countries ranking in January-March 2020, Total market, Value in Bln. USD and Units

RUSSIA

0,4

TOTAL MARKET

0,2

5,7

KAZAKHSTAN

BELARUS

UZBEKISTAN

AZERBAIJAN

GEORGIA

MOLDOVA

KYRGYZSTAN

ARMENIA

MONGOLIA

7,0

0,3

0,1

0,0

0,1

0,1

0,0

0,0

0,0

2,1

1,4

0,1

0,2

0,1

0,2

0,0

0,0

0,0

0,0

19%

26%

29%

-12%

14%

19%

0%

25%

28%

26%

53%

14%

8%

24%

5%

-1%

24%

6%

16%

34%

5%

10%

Total pharma sales

Bln Units, M03/YTD’20Growth

In percent in Units

Growth

In percent in Local Currency

24%

31%

19%

1%

19%

37%

31%

29%

0%

60%

3

Indicator RUB USD EUR PACKS

Value M03/YTD’20, Bln. 381 5,7 5,2 1,4

Growth M03/YTD’20% 31% 29% 33% 5,1%

Market grew by 31% in value and by 5,1% in volume

Russian pharma market growth in January-March 2020

Source: IQVIA databases. Retail, Public, DLO, RLO (excluding food supplements and diagnostic agents), TRD Prices

34

51

51

214

246

26

2230

M03/YTD’19 M03/YTD’20

292

381

+31%

Retail

Regional Reimbursement

Public (EXCL. DLO AND RLO)

Reimbursement

1,2 1,3

0,1

M03/YTD’19

0,1

M03/YTD’20

1,31,4

+5,1%

VALUE, BLN RUB VOLUME, BLN PACKS

+56%

+73%

+15%

+91%

+46%

+31%

+4,6%

-2,2%

4

Retail Sell-Out: Market grew by 14% in value and by 5% in volume

Russian pharma market growth in January-March 2020

Source: Pharmatrend (excluding food supplements and diagnostic agents), FIN Prices

VALUE, BLN RUB

YoY growth, % YoY growth, %

VOLUME, BLN PACKS

M03/YTD’19

50%

M03/YTD’20

50%

50%50%

260

297

+14%

OTC RX

35%

65%

35%

65%

M03/YTD’19 M03/YTD’20

1,231,29

+5,0%

+15%

+14%

+5,0%

+5,0%

5

Sell-In vs Sell-Out, OTC registered drugs

Source: Retail Audit and Pharmatrend. OTC registered drugs

150

200

300

250

350

2019/06

232

2019/09

218

2019/10

266

234

267

344

236

2019/03

254250

2019/04

249 232

229

230

2019/05

221

227

2019/07

237

261

2019/122019/08

257250

264

2020/032019/11

284

245241

337

252

2020/02

263

2020/01

Sell-In Sell-Out

Mln

pac

ks

6

TOP-15 corporations on Russian market, January-March 2020


SANOFI-AVENTIS

BAYER HEALTHCARE

Total pharma market

1,9%

JOHNSON & JOHNSON

NOVARTIS

2,2%

TAKEDA

GLAXOSMITHKLINE

OTCPHARM

SERVIER

MERCK SHARP DOHME

SANDOZ

TEVA

2,4%

PFIZER

100,0%

KRKA

4,5%

3,7%

3,5%

2,8%

2,7%

2,6%

2,2%

2,2%

2,2%

1,9%

1,9%

BIOCAD RF

ABBOTT 1,9%

26%

53%

17%

31%

78%

23%

79%

3%

14%

58%

26%

16%

4%

42%

82%

13%

10%

9%

5%

9%

11%

9%

13%

-6%

7%

5%

7%

0%

9%

10%

18%

-4%

Value growth / declineIn percent in Local Currency

Volume growth / declineIn percent in Packs

1

2

3

4

5

6

7

8

9

10

11

12

13

14

Market share, M03/YTD’20In percent in Local Currency

15

7

TOP-15 brands on Russian market, January-March 2020


INGAVIRIN

ELIQUIS

REVLIMIDE

Total pharma market

0,6%

XARELTO

TOUJEO SOLOSTAR

OPDIVO

KEYTRUDA

TIVICAY

ELIZARIA

100,0%

MIRAMISTIN

IMBRUVICA

0,5%

DARZALEX

1,4%

1,0%

0,6%

0,4%

0,6%

0,5%

0,5%

0,5%

0,5%

0,4%

0,4%

0,4%

0,4%

AVEGRA BIOCAD

DETRALEX

PRADAXA

162%

31%

273%

61%

39%

25%

10 746%

163%

31 875%

63%

128%

67%

3 099%

19%

61%

91% 96%

5%

275%

55%

2%

22%

162%

47%

121%

67%

10%

53%

56%

15 777%

38 333%

8 698%

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15




8

Advertisement cost,

Growth Y-to-Y

TOP-10 products by growth in advertisement investments in January-March 2020

Total sales

Bln RUB

Sales,

Growth Y-to-Y

144%

236%

1.000%

1.000%

1.000%

1.000%

1.000%

376%

220%

134%

RENNIE

MAGNELIS B6

HEPTRAL

ARBIDOL

ANTIGRIPPIN

CYTOVIR-3

INGAVIRIN

KETONAL

RELIEF

BEPANTHEN

1,86

1,29

0,78

0,59

2,44

0,71

0,47

0,63

0,85

0,85

36%

15%

32%

108%

28%

22%

10%

27%

20%

7%

The rank in calculated among TOP-200 Brands by sales with advertising cost greater than 50 mln RUB

Source: IQVIA databases. Pharmatrend, Mediascope data, FIN Prices

9

TOP-10 products by decline in advertisement investments in January-March 2020

-38%

-41%

-66%

-57%

-30%

-52%

-46%

-29%

-28%

-27%

TANTUM

LINEX

NO SPA

HEXORAL

PHOSPHALUGEL

0,93CYCLOFERON

RINZA

COMPLIVIT

POLYOXIDONIUM

ACC

0,91

0,92

0,50

0,97

0,74

1,34

0,40

0,65

1,28

26%

3%

16%

13%

10%

-7%

13%

-10%

13%

-48%

The rank in calculated among TOP-200 Brands by sales with advertising cost greater than 50 mln RUB

Source: IQVIA databases. Pharmatrend, Mediascope data, FIN Prices

Advertisement cost,

Growth Y-to-Y

Total sales

Bln RUB

Sales,

Growth Y-to-Y

10

Indicator KZT USD EUR PACKS

Value M03/YTD’20, Bln. 154 0,39 0,36 0,18

Growth M03/YTD’20% 24% 19% 23% 24%

Market grew by 24% in value and in volume

Kazakhstan pharma market growth in January-March 2020

Source: IQVIA databases. Retail, Hospital (excluding food supplements and diagnostic agents), TRD Prices

19

96

77

M03/YTD’19

32

16

39

M03/YTD’20

124

154

+24%

Retail

Hospital

Free & Co-Payment

0,02

0,13

0,16

0,01

M03/YTD’19 M03/YTD’20

0,15

0,18

+24%

VALUE, BLN KZT VOLUME, BLN PACKS

+24%

+25%

+17%

+14%

+24%

+32%

11

TOP-15 corporations on Kazakhstan market, January-March 2020


2,2%

TAKEDA

STADA

JOHNSON & JOHNSON

Total pharma market

NOBEL-AFF

SANOFI-AVENTIS

SERVIER

BAYER HEALTHCARE

ABBOTT

GLAXOSMITHKLINE

ROCHE

SANDOZ GROUP

NOVARTIS

TEVA

2,6%

100,0%

4,4%

5,8%

4,3%

3,8%

3,7%

3,2%

1,9%

2,9%

2,6%

2,4%

2,2%

1,9%

1,9%

SANTO

GEDEON RICHTER

24%

23%

17%

21%

43%

20%

-2%

24%

38%

28%

62%

14%

21%

31%

4%

0%

12%

10%

47%

30%

13%

24%

4%

33%

14%

37%

36%

30%

31%

8%

-1%

14%

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15




12

TOP-15 brands on Kazakhstan market, January-March 2020


NATRIUM CHLORIDUM

IMMUNATE

Total pharma market

0,6%

0,6%

IMMUTIN

SIMPONI

0,6%

0,6%CANEPHRON N

PHYSIOTENS

SUTENT

0,7%

THERAFLU

0,9%

ELAPRASE

VIFERON

0,6%

ACTOVEGIN

FLEMOXIN SOLUTAB

100,0%

1,0%

0,8%

0,8%

0,6%

0,8%

0,7%

0,7%

0,6%

SPIRITUS AETHYLIC

HERCEPTIN

OCTANATE

54%

24%

29%

96%

126%

40%

67%

37%

42%

15%

46%

11%

48%

41%

15%

83%

110%

97%

58%

24%

80%

38%

24%

46%

54%

38%

-5%

45%

8%

11%

25%

88%

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15




13

Indicator BLR USD EUR PACKS

Value M03/YTD’20, Bln. 0,58 0,26 0,23 0,10

Growth M03/YTD’20% 19% 14% 17% 14%

Market grew by 19% in value and by 14% in volume

Belarus pharma market growth in January-March 2020


0,38

0,11 0,11

0,47

M03/YTD’19 M03/YTD’20

0,49

0,58

+19%

Hospital

Retail

0.01

M03/YTD’20M03/YTD’19

0.080.09

0.01

0.09

0.10

+14%

VALUE, BLN BLR VOLUME, BLN PACKS

+23%

+3,8%

+16%

-0,8%

14

TOP-15 corporations on Belarus market, January-March 2020


BAYER HEALTHCARE

BELMEDPREP BEL

PHARMTECHNOLOG.BEL

PHARMLAND BEL

LEKFARM BELARUS

BORISOV.ZMP BEL

Total pharma market

MENARINI

SANDOZ GROUP

SANOFI-AVENTIS

2,1%

2,3%

MINSKINTERCAPS

KRKA

GEDEON RICHTER

SERVIER

TAKEDA

100,0%

8,0%

7,0%

5,9%

2,6%

3,7%

3,5%

3,2%

2,6%

3,2%

2,6%

2,4%

1,9%

2,2%

GLAXOSMITHKLINE

36%

9%

19%

22%

23%

36%

25%

5%

23%

22%

6%

22%

42%

27%

23%

-25%

14%

0%

22%

15%

8%

30%

24%

28%

28%

11%

11%

14%

29%

-8%

29%

24%

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15




15

TOP-15 brands on Belarus market, January-March 2020


0,9%ADVAGRAF

CO-AMLESSA

Total pharma market

XARELTO

NATRIUM CHLORIDUM

ARPETOL

FLUSTOP

GLICLAZIDE MR

0,5%

GROPRINOSIN

AUGMENTIN

0,8%

PROTAMIN-INSUL. HS

ACTOVEGIN

PHENYBUT

OMEPRAZOL

VIMIZAIM

100,0%

0,5%

1,2%

0,8%

0,8%

0,6%

0,6%

0,5%

0,5%

0,4%

0,4%

CEREPRO

0,4%

0,4%

68%

9%

11%

19%

47%

122%

44%

310%

18%

-1%

47%

171%

49%

417%

35%

16%

14%

46%

57%

420%

44%

15%

388%

-3%

18%

43%

165%

49%

67%

9%

122%

-28%

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15




16

Indicator UZS USD EUR PACKS

Value M03/YTD’20, Bln. 2 119 0,22 0,20 0,16

Growth M03/YTD’20% 0,6% -12% -9% -1,0%

Market grew by 0,6% in value and decreased by 1,0% in volume

Uzbekistan pharma market growth in January-March 2020

Source: IQVIA databases. Retail and Hospital Market (exclude food supplements and diagnostic agents), TRD Prices

M03/YTD’20M03/YTD’19

2 1192 107

+0,6%

Retail, Hospital

M03/YTD’19 M03/YTD’20

0,160,16

-1,0%

VALUE, BLN UZS VOLUME, BLN PACKS

17

TOP-15 corporations on Uzbekistan market, January-March 2020


KRKA

1,8%

MARION BIOTECH

2,3%

MENARINI

2,5%

5,2%

Total pharma market

RADIKS NPP

SANOFI-AVENTIS

GM PHARMACEUTICALS

GEDEON RICHTER

ABBOTT

ZHURABEK LAB

YURIA-FARM UKR

FARMAK KIEV

ARTERIUM

2,1%

3,7%

NOVARTIS

100,0%

3,0%

2,8%

2,5%

2,3%

2,3%

2,2%

2,0%

1,7%

1,7%

NOBEL ILAC SAN TUR

STADA

65%

81%

1%

13%

38%

37%

35%

79%

52%

5%

51%

14%

21%

-12%

15%

14%

45%

13%

41%

-1%

-4%

77%

63%

-2%

9%

59%

2%

55%

11%

-4%

25%

-9%

Value growth / decline Volume growth / decline

1

2

3

4

5

6

7

8

9

10

11

12

13

14

Market share, M03/YTD’20

15

18

TOP-15 brands on Uzbekistan market, January-March 2020


QUPEN

CEFTRIAXONE

GARDASIL

Total pharma market

NIMESIL

1,3%ACTOVEGIN

0,7%

1,1%

ZIMOKARD MR

RHEOSORBILACT

SODIUM CHLORIDE

VIFERON

0,7%

L-LYSINE AESCINAT

0,6%

CARDIOMAGNYL

CALCIUM-D3 NYCOMED

CANEPHRON N

IMUDON

100,0%

1,1%

1,1%

0,9%

0,8%

0,6%

0,6%

0,6%

0,5%

0,5%

1,0%

MYDOCALM-RICHTER

13%

1%

17%

152%

32%

-3%

188%

7%

45%

101%

478%

1 127%

1 946%

-12%

-11%

405%

861%

1 881%

-38%

24%

-2%

-1%

1%

152%

35%

-2%

21%

153%

-36%

42%


1

2

3

4

5

6

7

8

9

10

11

12

13

14


15

19

Indicator KGS USD EUR PACKS

Value M03/YTD’20, Bln. 3,5 0,05 0,04 0,05

Growth M03/YTD’20% 29% 26% 30% 34%

Market grew by 29% in value and by 34% in volume

Kyrgyzstan pharma market growth in January-March 2020


3,5

M03/YTD’19 M03/YTD’20

2,7

+29%

Retail, Hospital

M03/YTD’19 M03/YTD’20

0,04

0,05

+34%

VALUE, BLN KGS VOLUME, BLN PACKS

20

TOP-15 corporations on Kyrgyzstan market, January-March 2020


ABBOTT

SYNTEZ

KRKA

NOVARTIS

3,4%

NOBEL ILAC SAN TUR

Total pharma market

SANTO

WORLD MEDICINE

STADA

MENARINI

GEDEON RICHTER

100,0%

BORISOV.ZMP BEL

MATERIA MEDICA

BIOVIT KIRGIZIA

5,0%

4,3%

4,1%

3,9%

3,3%

3,3%

3,2%

2,0%

2,4%

2,1%

2,0%

1,9%

1,9%

1,8%FARMAK KIEV

ROCHE

53%

310%

33%

18%

44%

29%

-10%

21%

27%

27%

19%

106%

33%

185%

30%

14%

34%

17%

17%

45%

137%

33%

46%

77%

45%

33%

13%

23%

263%

-13%

5%

43%


1

2

3

4

5

6

7

8

9

10

11

12

13

14


15

21

TOP-15 brands on Kyrgyzstan market, January-March 2020


0,8%

100,0%Total pharma market

CEFAZOLIN-AKOS

TYLOL HOT

ANAFERON FOR KIDS

0,7%

CEFTRIAXONE

0,7%

SODIUM CHLORIDE

ACTOVEGIN

VIFERON

ERGOFERON

FLEMOXIN SOLUTAB

THERAFLU

CANEPHRON N

0,9%

CARDIOMAGNYL

HEPTRAL

0,8%

ACC-LONG

ANTIGRIPPIN

1,4%

1,3%

0,9%

0,9%

0,8%

0,7%

0,6%

0,6%

0,5%

0,5%

29%

240%

29%

16%

3 095%

22%

17%

115%

40%

80%

30%

6%

4%

93%

161%

258%

22%

233%

34%

39%

22%

4%

25%

35%

122%

3 577%

84%

11%

2%

93%

120%

252%


1

2

3

4

5

6

7

8

9

10

11

12

13

14


15

22

Indicator MNT USD EUR PACKS

Value M03/YTD’20, Bln. 72 0,03 0,02 0,01

Growth M03/YTD’20% 60% 53% 58% 10%

Market increased by 60% value and by 10% in volume

Mongolian pharma market growth in January-March 2020

Source: IQVIA databases. Import statistics (exclude food supplements and diagnostic agents), TRD Prices

M03/YTD’19

45

M03/YTD’20

72

+60%

Import

0,01

M03/YTD’19 M03/YTD’20

0,01

+10%

VALUE, BLN MNT VOLUME, BLN PACKS

23

TOP-15 corporations on Mongolian market, January-March 2020


ASTELLAS PHARMA 13,3%

SANDOZ

DENK PHARMA

KRKA

1,5%

Total pharma market

GEDEON RICHTER

8,2%

HERBION PAKISTAN

NOVARTIS

HIMALAYA

GLAXOSMITHKLINE

3,8%

BAYER HEALTHCARE

2,1%

KALBE FARMA TBK

2,6%

SK PLASMA

STADA

MENARINI

100,0%

12,3%

1,3%

8,5%

3,8%

2,3%

1,5%

1,5%

1,4%

1,3%

MATERIA MEDICA

209%

228%

60%

39%

-16%

11%

171%

28%

17%

1 467%

116%

-14%

54%

51%

213%

10%

10%

-34%

-29%

322%

62%

229%

41%

5%

1%

200%

1 227%

55%

-31%

10%


1

2

3

4

5

6

7

8

9

10

11

12

13

14


15

24

TOP-15 brands on Mongolian market, January-March 2020


4,6%ALBUMIN

1,2%

FLEMOXIN SOLUTAB

DIROTON

Total pharma market

THERAFLU

1,8%DICLO-DENK 100 RET

IBUPROFEN-DENK

AMLO-DENK 10

SUPRAX SOLUTAB

PROGRAF

EKVATOR

DICLO-DENK 100 REC

FLEMOCLAV SOLUTAB

NOLPAZA

100,0%

1,6%

6,2%

2,5%

2,3%

1,5%

1,4%

1,2%

1,2%

1,1%

1,1%

1,1%

1,1%

GLIVEC

ACC

18%

241%

60%

44%

1 396%

8%

119%

336%

55%

37%

79%

281%

269%

248%

39%

43%

254%

10%

1 979%

12%

328%

231%

112%

67%

60%

272%

343%

20%


1

2

3

4

5

6

7

8

9

10

11

12

13

14


15

CONTACT USAnton Kalyapin

Associate Director, Offering and Supplier Relations

[email protected]

Katerina Padolka

Sales lead

+7 499 272 05 00

[email protected]

+7 499 272 05 00

Nadezhda Kalinich

Client Service Representative

[email protected]

+7 499 272 05 00

Documents

Facts from IQVIA · 2020. 6. 18. · 3 Indicator RUB USD EUR PACKS Value M03/YTD’20, Bln. 381 5,7 5,2 1,4 Growth M03/YTD’20% 31% 29% 33% 5,1% Market grew by 31% in value and by